{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T11:18:02Z","timestamp":1787829482848,"version":"build-2784847793"},"reference-count":16,"publisher":"Index Copernicus","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Otolaryngol Pol"],"published-print":{"date-parts":[[2026,3,19]]},"abstract":"<b>Introduction:<\/b> Although genetic mutations have been reported in salivary duct carcinoma (SDC), no scientifically validated targeted therapies are currently available. Moreover, cancer genomic profiling tests remain underutilized in clinical practice. These issues highlight the urgent need to elucidate the genomic landscape of SDC and its potential therapeutic relevance. <br><br><b>Aim:<\/b> This study aimed to characterize the mutational profile of recurrent and\/or metastatic SDC. <br><br><b>Materials and methods:<\/b> Data were analyzed for 207 consecutive patients with SDC registered at the Japan National Cancer Center, Center for Cancer Genomics and Advanced Therapeutics (C-CAT) between June 2019 and October 2025. Genetic mutations were determined by next-generation sequencing. Survival of patients was determined by the log-rank test and the Cox proportional hazards model. <br><br><b>Results:<\/b> The top 10 mutations in SDC were <i>TP53<\/i> (74.4%), <i>ERBB2<\/i> (52.2%), <i>NF1<\/i> (32.4%), <i>CDK12<\/i> (29.0%), <i>PIK3CA<\/i> (28.0%), <i>NOTCH3<\/i> (19.8%), <i>LTK<\/i> (18.4%), <i>CDKN2A<\/i> (18.4%), <i>BRCA2<\/i> (16.9%), <i>SPEN<\/i> (16.9%), with 17.1 7.2 (mean standard error of the mean [SEM]) mutations\/individual. <i>TP53<\/i> mutations (p = 0.005707) were associated with a significantly worse prognosis, as determined by log-rank test. The hazard ratios for cases with this mutation was 2.6390 (95% CI, 1.2180\u20135.720, p = 0.0139) for <i>TP53<\/i>. <br><br><b>Conclusions:<\/b> This study delineated the mutational spectrum of recurrent and\/or metastatic SDC. Even in advanced disease, prognostically relevant mutations were identified, emphasizing the clinical importance of cancer genomic profiling tests.<\/ns3:p>","DOI":"10.5604\/01.3001.0055.5900","type":"journal-article","created":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T10:16:53Z","timestamp":1773915413000},"page":"7-13","source":"Crossref","is-referenced-by-count":0,"title":["Genetic mutations in salivary duct carcinoma"],"prefix":"10.5604","volume":"80","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9080-7259","authenticated-orcid":false,"given":"Hiromi","family":"Nagano","sequence":"first","affiliation":[{"name":"Department of Otolaryngology Head and Neck Surgery, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-8523-9131","authenticated-orcid":false,"given":"Satoshi","family":"Kiyama","sequence":"additional","affiliation":[{"name":"Department of Otolaryngology Head and Neck Surgery, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-7415-6759","authenticated-orcid":false,"given":"Takayuki","family":"Kyutoku","sequence":"additional","affiliation":[{"name":"Department of Otolaryngology Head and Neck Surgery, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-2562-7806","authenticated-orcid":false,"given":"Hayato","family":"Matsumoto","sequence":"additional","affiliation":[{"name":"Department of Otolaryngology Head and Neck Surgery, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9861-1517","authenticated-orcid":false,"given":"Masaru","family":"Yamashita","sequence":"additional","affiliation":[{"name":"Department of Otolaryngology Head and Neck Surgery, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3689","reference":[{"key":"635826r1","doi-asserted-by":"crossref","unstructured":"Kanno M., Kano S., Imamura Y. et al.: Palliative systemic therapy for locally advancedor metastatic salivary duct carcinoma: A comprehensive review. CancerTreat Rev., 2025; 139: 102993. doi: 10.1016\/j.ctrv.2025.102993.","DOI":"10.1016\/j.ctrv.2025.102993"},{"key":"635826r2","doi-asserted-by":"crossref","unstructured":"Shimura T., Tada Y., Hirai H. et al.: Prognostic and histogenetic roles of genealteration and the expression of key potentially actionable targets in salivaryduct carcinomas. Oncotarget. Oncotarget., 2017; 9(2): 1852\u20131867. doi:10.18632\/oncotarget.22927.","DOI":"10.18632\/oncotarget.22927"},{"key":"635826r3","doi-asserted-by":"crossref","unstructured":"Nagano H., Matsumoto H., Ando Y. et al.: Genetic mutations in recurrent and\/or metastaticnasopharyngeal carcinoma \u2013 an analysis of the Japanese national genomic profilingdatabase. Otolaryngol Pol., 2025; 79(4): 34\u201339. doi: 10.5604\/01.3001.0055.1903.","DOI":"10.5604\/01.3001.0055.1903"},{"key":"635826r4","doi-asserted-by":"crossref","unstructured":"Iwaki S., Kawakita, D., Nagao T. et al.: Comprehensive genomic profiling of salivarygland carcinoma: Analysis of the Center for Cancer Genomics and AdvancedTherapeutics database in Japan. Int J Cancer., 2024; 155(5): 871\u2013882.doi: 10.1002\/ijc.34972.","DOI":"10.1002\/ijc.34972"},{"key":"635826r5","doi-asserted-by":"crossref","unstructured":"Mukai Y., Ueno H.: Establishment and implementation of cancer genomic medicinein Japan. Cancer Sci., 2021; 112(3): 970\u2013977. doi: 10.1111\/cas.14754.","DOI":"10.1111\/cas.14754"},{"key":"635826r6","doi-asserted-by":"crossref","unstructured":"Kanda Y.: Investigation of the freely available easy-to-use software \u2018EZR\u2019for medical statistics. Bone Marrow Transplant., 2013; 48(3): 452\u2013458. doi:10.1038\/bmt.2012.244.","DOI":"10.1038\/bmt.2012.244"},{"key":"635826r7","doi-asserted-by":"crossref","unstructured":"Nakaguro M., Tada Y., Faquin W.C. et al.: Salivary duct carcinoma: Updatesin histology, cytology, molecular biology, and treatment. Cancer Cytopathol.,2020; 128(10): 693\u2013703. doi: 10.1002\/cncy.22288.","DOI":"10.1002\/cncy.22288"},{"key":"635826r8","doi-asserted-by":"crossref","unstructured":"Di Palma S., Simpson RH., Marchi\u00f2 C. et al.: Salivary duct carcinomas canbe classified into luminal androgen receptor-positive, HER2 and basal-likephenotypes. Histopathology., 2012; 61(4): 629\u2013643. doi: 10.1111\/j.1365--2559.2012.04252.x.","DOI":"10.1111\/j.1365-2559.2012.04252.x"},{"key":"635826r9","doi-asserted-by":"crossref","unstructured":"Sk\u00e1lov\u00e1 A., Plank L., St\u00e1rek I., Sz\u00e9pe P., Plank L.: Salivary duct carcinoma \u2013 a highlyaggressive salivary gland tumor with HER-2\/neu oncoprotein overexpression.Pathol Res Pract., 2001; 197(9): 621\u2013626. doi: 10.1078\/0344-0338-00136.","DOI":"10.1078\/0344-0338-00136"},{"key":"635826r10","doi-asserted-by":"crossref","unstructured":"Kohno T., Kato M., Kohsaka S. et al.: C-CAT: the national datacenter for cancergenomic medicine in Japan. Cancer Discov., 2022; 12(11): 2509\u20132515. doi:10.1158\/2159-8290.CD-22-0417.","DOI":"10.1158\/2159-8290.CD-22-0417"},{"key":"635826r11","doi-asserted-by":"crossref","unstructured":"Ebi H., Bando H.: Precision oncology and the Universal Health Coverage Systemin Japan. JCO Precis Oncol., 2019; 3: PO.19.00291. doi: 10.1200\/PO.19.00291.","DOI":"10.1200\/PO.19.00291"},{"key":"635826r12","doi-asserted-by":"crossref","unstructured":"Wang K., Russell J.S., McDermott J.D. et al.: Profiling of 149 SalivaryDuct Carcinomas, Carcinoma Ex Pleomorphic Adenomas, and Adenocarcinomas,Not Otherwise Specified Reveals Actionable Genomic Alterations.Clin Cancer Res., 2016; 22(24): 6061\u20136068. doi: 10.1158\/1078-0432.CCR-15-2568.","DOI":"10.1158\/1078-0432.CCR-15-2568"},{"key":"635826r13","doi-asserted-by":"crossref","unstructured":"Dalin M.G., Desrichard A., Katabi N. et al.: Comprehensive Molecular Characterizationof Salivary Duct Carcinoma Reveals Actionable Targets and Similarityto Apocrine Breast Cancer. Clin Cancer Res., 2016; 22(18): 4623\u20134633.doi: 10.1158\/1078-0432.CCR-16-0637.","DOI":"10.1158\/1078-0432.CCR-16-0637"},{"key":"635826r14","doi-asserted-by":"crossref","unstructured":"Santana T., Pavel A., Martinek P. et al.: Biomarker immunoprofile andmolecular characteristics in salivary duct carcinoma: clinicopathologicaland prognostic implications. Hum Pathol., 2019; 93: 37\u201347. doi: 10.1016\/j.humpath.2019.08.009.","DOI":"10.1016\/j.humpath.2019.08.009"},{"key":"635826r15","doi-asserted-by":"crossref","unstructured":"Sk\u00e1lov\u00e1 A., Stenman G., Simpson R.H.W. et al.: The role of molecular testingin the differential diagnosis of salivary gland carcinomas. Am J Surg Pathol.,2018; 42(2): e11\u2013e27. doi: 10.1097\/PAS.0000000000000980.","DOI":"10.1097\/PAS.0000000000000980"},{"key":"635826r16","doi-asserted-by":"crossref","unstructured":"Mochizuki T., Ikegami M., Akiyama T.: Factors predictive of second-line chemotherapyin soft tissue sarcoma: an analysis of the national genomic profilingdatabase. Cancer Sci., 2024; 115(2): 575\u2013588. doi: 10.1111\/cas.16050.","DOI":"10.1111\/cas.16050"}],"container-title":["Otolaryngologia Polska"],"original-title":[],"link":[{"URL":"https:\/\/otolaryngologypl.com\/gicid\/pdf\/01.3001.0055.5900","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/otolaryngologypl.com\/gicid\/pdf\/01.3001.0055.5900","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T10:21:57Z","timestamp":1787826117000},"score":1,"resource":{"primary":{"URL":"https:\/\/otolaryngologypl.com\/gicid\/01.3001.0055.5900"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,19]]},"references-count":16,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,5,7]]}},"URL":"https:\/\/doi.org\/10.5604\/01.3001.0055.5900","relation":{},"ISSN":["0030-6657","2300-8423"],"issn-type":[{"value":"0030-6657","type":"print"},{"value":"2300-8423","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,19]]}}}